Viewing Study NCT02341560


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-03-01 @ 4:13 PM
Study NCT ID: NCT02341560
Status: TERMINATED
Last Update Posted: 2020-07-20
First Post: 2015-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Sponsor: Quark Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module